306 related articles for article (PubMed ID: 18972260)
1. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes.
Christiansen MS; Hommel E; Friberg L; Mølvig J; Magid E; Feldt-Rasmussen B
J Diabetes Complications; 2010; 24(1):28-36. PubMed ID: 18818101
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
4. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
7. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss.
Martos R; Valle M; Morales RM; Cañete R; Gascón F; Urbano MM
Metabolism; 2009 Aug; 58(8):1153-60. PubMed ID: 19477472
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training.
Ostergård T; Nyholm B; Hansen TK; Rasmussen LM; Ingerslev J; Sørensen KE; Bøtker HE; Saltin B; Schmitz O
Metabolism; 2006 Nov; 55(11):1508-15. PubMed ID: 17046554
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
[TBL] [Abstract][Full Text] [Related]
10. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
11. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
[TBL] [Abstract][Full Text] [Related]
12. Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM).
Kvasnicka J; Skrha J; Perusicová J; Kvasnicka T; Marková M; Umlaufová A; Pecen L
Sb Lek; 1998; 99(2):97-101. PubMed ID: 10536488
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
15. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
Sokup A; Góralczyk B; Góralczyk K; Rość D
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):182-8. PubMed ID: 21954994
[TBL] [Abstract][Full Text] [Related]
16. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
[TBL] [Abstract][Full Text] [Related]
17. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
[TBL] [Abstract][Full Text] [Related]
18. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
Horm Metab Res; 2010 Jan; 42(1):8-13. PubMed ID: 19735057
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
